Recombinant Liver Protein Patent Valid, Infringed, Panel Affirms
Mealey's (March 3, 2021, 11:50 AM EST) -- WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals in a March 1 holding left intact a jury’s verdict that a Bayer Healthcare LLC patent directed to recombinant forms of...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login